Gemini Therapeutics Inc Ordinary Shares (NASDAQ:GMTX)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - GMTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - GMTX

  • Market Cap$498.550m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS36870G1058

Company Profile

Gemini Therapeutics Inc is a clinical-stage precision medicine company developing novel therapeutic compounds to treat genetically defined AMD. Its candidate, GEM103, is a recombinant form of the Complement Factor H protein (CFH) and is designed to address both complement hyperactivity and restore retinal health. Variations in the gene that encodes CFH strongly correlate with an increased risk of developing AMD.

Latest GMTX news

Currently there for this company. Visit our news hub for other news .